Yossi Maimon

Yossi Maimon is an accomplished financial executive with extensive experience in Chief Financial Officer roles across various companies. Currently serving as the Chief Financial Officer at Scopio Labs since 2024, Yossi previously held the same position at Quris Ai from 2023 to 2024, and at Ayala Pharmaceuticals from 2019 to 2023. Yossi's earlier experience includes a long tenure at Protalix Biotherapeutics from 2006 to 2019 and a position at ColBar LifeScience Ltd. from 2002 to 2006. Yossi Maimon holds a Master of Business Administration (M.B.A.) in Finance from Tel Aviv University and a degree in Accounting from The City University of New York.